Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Urate transporter 1 (URAT1), encoded by the SLC22A12 gene, is a membrane protein responsible for the high-affinity reabsorption of uric acid in the renal proximal tubule, critically regulating serum uric acid levels[1][4][7]. It functions as an antiporter, mediating the uptake of extracellular urate typically in exchange for organic anions or chloride ions, thus playing a key role in both urate reabsorption in the kidney and influencing overall body urate balance[1][2]. URAT1 is a member of the solute carrier 22 (SLC22) family of organic anion transporters, predominantly expressed in the apical membrane of proximal tubular cells, and is a therapeutic target for uricosuric drugs used to treat gout and hyperuricemia[4][7].
Inhibition of uric acid reabsorption by competitive binding to the transporter (uricosuric effect) Antagonism of substrate (urate) uptake
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Urate transporter 1 (URAT1).